Efficacy and safety of oral methazolamide in patients with type 2 diabetes : a 24-week, placebo-controlled, double-blind study

Simpson, RW; Nicholson, GC; Proietto, J; Sarah, A; Sanders, KM; Phillips, G; Chambers, J; MacGinley, R; Orford, Neil; Walder, Ken; Krippner, G; Skoff, K; Wacher, VJ

Efficacy and safety of oral methazolamide in patients with type 2 diabetes : a 24-week, placebo-controlled, double-blind study

https://hdl.handle.net/10536/DRO/DU:30070253
Open external identifier URL

journal contribution

posted on 2024-06-04, 04:40 authored by RW Simpson, GC Nicholson, J Proietto, A Sarah, KM Sanders, G Phillips, J Chambers, R MacGinley, Neil OrfordNeil Orford, Ken WalderKen Walder, G Krippner, K Skoff, VJ Wacher

To evaluate the safety and efficacy of methazolamide as a potential therapy for type 2 diabetes.

History

Related Materials

1.
DOI - Is version of https://doi.org/10.2337/dc14-1038

Location

Alexandria VA.

Language

eng

Author URL

http://www.ncbi.nlm.nih.gov/pubmed/25125506

Publication classification

C Journal article, C1 Refereed article in a scholarly journal

Copyright notice

2014, American Diabetes Association

Journal

Diabetes Care

Volume

37

Pagination

3121-3123

eISSN

1935-5548

Issue

11

Publisher

American Diabetes Association

Usage metrics

Keywords

School of Medicine 119999 Medical and Health Sciences not elsewhere classified 920104 Diabetes

Efficacy and safety of oral methazolamide in patients with type 2 diabetes : a 24-week, placebo-controlled, double-blind study

History

Related Materials

Location

Language

Author URL

Publication classification

Copyright notice

Journal

Volume

Pagination

eISSN

Issue

Publisher

Usage metrics

Categories

Keywords

Licence

Exports